Tags

Type your tag names separated by a space and hit enter

Gout: Rapid Evidence Review.
Am Fam Physician. 2020 Nov 01; 102(9):533-538.AF

Abstract

Gout is caused by monosodium urate crystal deposition in joints and tissues. Risk factors include male sex; obesity; hypertension; alcohol intake; diuretic use; a diet rich in meat and seafood; chronic kidney disease; a diet heavy in fructose-rich food and beverages; being a member of certain ethnic groups, including Taiwanese, Pacific Islander, and New Zealand Maori; and living in high-income countries. Gout is characterized by swelling, pain, or tenderness in a peripheral joint or bursa, including the development of a tophus. Diagnosis of gout can be made using several validated clinical prediction rules. Arthrocentesis should be performed when suspicion for an underlying septic joint is present; synovial fluid or tophus analysis should be performed if the diagnosis is uncertain. Colchicine, nonsteroidal anti-inflammatory drugs, and corticosteroids relieve pain in adults with acute gout episodes. Indications for long-term urate-lowering therapy include chronic kidney disease, two or more flare-ups per year, urolithiasis, the presence of tophus, chronic gouty arthritis, and joint damage. Allopurinol and febuxostat are used to prevent flare-ups, although febuxostat is associated with an increase in all-cause and cardiovascular mortality and is therefore not routinely recommended.

Authors+Show Affiliations

Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

33118789

Citation

Clebak, Karl T., et al. "Gout: Rapid Evidence Review." American Family Physician, vol. 102, no. 9, 2020, pp. 533-538.
Clebak KT, Morrison A, Croad JR. Gout: Rapid Evidence Review. Am Fam Physician. 2020;102(9):533-538.
Clebak, K. T., Morrison, A., & Croad, J. R. (2020). Gout: Rapid Evidence Review. American Family Physician, 102(9), 533-538.
Clebak KT, Morrison A, Croad JR. Gout: Rapid Evidence Review. Am Fam Physician. 2020 11 1;102(9):533-538. PubMed PMID: 33118789.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Gout: Rapid Evidence Review. AU - Clebak,Karl T, AU - Morrison,Ashley, AU - Croad,Jason R, PY - 2020/10/29/entrez PY - 2020/10/30/pubmed PY - 2021/1/1/medline SP - 533 EP - 538 JF - American family physician JO - Am Fam Physician VL - 102 IS - 9 N2 - Gout is caused by monosodium urate crystal deposition in joints and tissues. Risk factors include male sex; obesity; hypertension; alcohol intake; diuretic use; a diet rich in meat and seafood; chronic kidney disease; a diet heavy in fructose-rich food and beverages; being a member of certain ethnic groups, including Taiwanese, Pacific Islander, and New Zealand Maori; and living in high-income countries. Gout is characterized by swelling, pain, or tenderness in a peripheral joint or bursa, including the development of a tophus. Diagnosis of gout can be made using several validated clinical prediction rules. Arthrocentesis should be performed when suspicion for an underlying septic joint is present; synovial fluid or tophus analysis should be performed if the diagnosis is uncertain. Colchicine, nonsteroidal anti-inflammatory drugs, and corticosteroids relieve pain in adults with acute gout episodes. Indications for long-term urate-lowering therapy include chronic kidney disease, two or more flare-ups per year, urolithiasis, the presence of tophus, chronic gouty arthritis, and joint damage. Allopurinol and febuxostat are used to prevent flare-ups, although febuxostat is associated with an increase in all-cause and cardiovascular mortality and is therefore not routinely recommended. SN - 1532-0650 UR - https://www.unboundmedicine.com/medline/citation/33118789/full_citation DB - PRIME DP - Unbound Medicine ER -